MedPath

TREATMENT FOR EAR DISCHARGE USING KUSHTADI TAILA AND CIPROFLOXACIN EAR DROPS

Phase 2
Completed
Conditions
Health Condition 1: H661- Chronic tubotympanic suppurative otitis media
Registration Number
CTRI/2019/09/021197
Lead Sponsor
Department of shalakya tantra
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1.Patients presenting with features of Safe Chronic Suppurative Otitis media for more than 3 months.

2.Patients in the age group of 6 to 40 year and irrespective of gender.

Exclusion Criteria

1.Ear discharge associated with complications such as cholesteatoma, polyps, granulation tissue, and purulent discharge with foul smell.

2. Patients with immune compromised diseases.

3.Pregnant and lactating women.

4.Attic and total perforations.

5.Patients with severe conductive deafness, mixed deafness.

6.Patients with blood stained ear discharge.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath